Charles River Laboratories International (CRL) Earnings Date, Estimates & Call Transcripts $144.25 +5.46 (+3.93%) As of 01:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Charles River Laboratories International Earnings Summary Charles River Laboratories International posted Q1 2025 earnings on May 7, 2025, reporting an EPS of $2.34, which beat the consensus estimate of $2.06 by $0.28. Quarterly revenue fell 2.7% year-over-year to $984.17 million, above analyst estimates of $942.34 million. With a trailing EPS of -$0.65 and a P/E Ratio of 961.49, Charles River Laboratories International's earnings are expected to grow 17.52% next year, from $9.36 to $11.00 per share. Latest Q1 Earnings DateMay. 7EstimatedConsensus EPS (May. 7) $2.06 Actual EPS (May. 7) $2.34 Beat By $0.28 Actual Revenue (May. 7) $984.17MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)SEC FilingSlide DeckFull Screen Slide DeckPowered by Get Charles River Laboratories International Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Charles River Laboratories International and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCRL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CRL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Charles River Laboratories International Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252$2.06$2.06$2.06Q2 20252$2.29$2.49$2.39Q3 20252$2.40$2.44$2.42Q4 20252$2.52$2.55$2.54 FY 2025 8 $9.27 $9.54 $9.41 Q1 20262$2.44$2.74$2.59Q2 20262$2.46$2.74$2.60Q3 20262$2.63$2.65$2.64Q4 20262$2.68$2.72$2.70 FY 2026 8 $10.21 $10.85 $10.53 Q1 20271$2.65$2.65$2.65 Charles River Laboratories International Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025$2.06$2.34+$0.28$0.50$942.34M$984.17M2/19/2025Q4 2024$2.50$2.66+$0.16-$4.22$983.63M$1.00B11/6/2024Q3 2024$2.43$2.59+$0.16$3.85$975.99M$1.01B8/7/2024Q2 2024$2.39$2.80+$0.41$3.86$1.03B$1.03B5/9/2024Q1 2024$2.05$2.27+$0.22$3.24$997.24M$1.01B2/14/2024Q4 2023$2.39$2.46+$0.07$1.30$991.25M$1.01B11/8/2023Q3 2023$2.35$2.72+$0.37$3.75$1.00B$1.03B8/9/2023Q2 2023$2.63$2.69+$0.06$3.49$1.05B$1.06B Charles River Laboratories International Earnings - Frequently Asked Questions When did Charles River Laboratories International announce their last quarterly earnings? Charles River Laboratories International (NYSE:CRL) last announced its quarterly earning data on Wednesday, May 7, 2025. Learn more on CRL's earnings history. What guidance has Charles River Laboratories International issued on next quarter's earnings? Charles River Laboratories International issued an update on its FY 2025 earnings guidance on Wednesday, May, 7th. The company provided earnings per share (EPS) guidance of 9.300-9.800 for the period, compared to the consensus earnings per share estimate of 9.310. The company issued revenue guidance of $3.8 billion-$3.9 billion, compared to the consensus revenue estimate of $3.8 billion. Did Charles River Laboratories International beat their earnings estimates last quarter? In the previous quarter, Charles River Laboratories International (NYSE:CRL) reported $2.34 earnings per share (EPS) to beat the analysts' consensus estimate of $2.06 by $0.28. Learn more on analysts' earnings estimate vs. CRL's actual earnings. How can I listen to Charles River Laboratories International's earnings conference call? The conference call for Charles River Laboratories International's latest earnings report can be listened to online. Listen to Conference Call How can I read Charles River Laboratories International's conference call transcript? The conference call transcript for Charles River Laboratories International's latest earnings report can be read online. Read Transcript How can I view Charles River Laboratories International's earnings report? Charles River Laboratories International's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Charles River Laboratories International generate each year? Charles River Laboratories International (NYSE:CRL) has a recorded annual revenue of $4.02 billion. How much profit does Charles River Laboratories International generate each year? Charles River Laboratories International (NYSE:CRL) has a recorded net income of $474.62 million. CRL has generated -$0.65 earnings per share over the last four quarters. What is Charles River Laboratories International's price-to-earnings ratio? Charles River Laboratories International (NYSE:CRL) has a trailing price-to-earnings ratio of 968.98 and a forward price-to-earnings ratio of 15.53. The price/earnings-to-growth ratio is 4.54. What is Charles River Laboratories International's EPS forecast for next year? Charles River Laboratories International's earnings are expected to grow from $9.36 per share to $11.00 per share in the next year, which is a 17.52% increase. More Earnings Resources from MarketBeat Related Companies MTD Earnings Results WAT Earnings Results ILMN Earnings Results TECH Earnings Results BIO Earnings Results BRKR Earnings Results PACB Earnings Results HBIO Earnings Results TMO Earnings Results A Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? This page (NYSE:CRL) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredVIDEO: Strange New Elon Device to Shock the WorldElon Musk’s Next BIG Bet And this time he plans to dominate a market worth $3.2 trillion. That’s why I’m...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
